In "E4hAkita" mice, the mouse apolipoprotein E is replaced with a human apoE4 isoform and the mouse low density lipoprotein receptor is replaced with a transcript-stabilized human LDLR that expresses at three times that of wildtype endogenous levels. Also present is the Ins2Akita allele which causes insulin dependent diabetes. E4hAkita mice are diabetic with atherosclerosis and may be useful in applications related to the study of lipoprotein metabolism-related genes in diabetes, atherosclerosis, dyslipidemia, and vascular complications.
Dr. Nobuyo Maeda, University of North Carolina at Chapel Hill
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Spontaneous | Ins2 | insulin II |
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Inserted expressed sequence, Humanized sequence) | Apoe | apolipoprotein E |
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Inserted expressed sequence, Humanized sequence) | Ldlr | low density lipoprotein receptor |
Apoe4 Ldlrh Ins2C96Y mice harbor two humanized knock-in mutations, the human APOE*4 replacement allele (Apoetm3(APOE*4)Mae) and the human LDLR replacement allele (Ldlrtm1(LDLR)Mae), along with the dominant type 1 diabetes mutation Akita (Ins2Akita). Unless noted otherwise, the phenotypes below are for mice maintained on regular chow (~5% fat; <0.1% cholesterol).
The human APOE*4 replacement allele (Apoe4 or E4) expresses the human apoE4 isoform in place of the endogenous apoE protein. Under direction of the endogenous mouse apoE promoter/regulatory regions, human apoE4 expression is observed at physiological levels in the same temporal and spatial pattern observed in humans. Mice homozygous for human APOE*4 (Apoe4/4) are viable and fertile with normal plasma lipid and lipoprotein profiles. Apoe4/4 show mild retinal changes with aging. When maintained on high fat/cholesterol diet mirroring that consumed by humans, Apoe4/4 exhibit increased susceptibility to atherosclerosis, impaired glucose tolerance, fat overload, amyloid beta immunoreactivity, degenerative changes in the retina and other metabolic defects.
The human LDLR replacement allele (Ldlrh) has the promoter/regulatory regions and exon 1 (encoding only the signal peptide) from endogenous mouse Ldlr directing expression of a human LDLR sequence modified to have increased mRNA transcript stability; this results in expression of hLDLR protein in place of endogenous mouse Ldlr protein, with three-fold greater levels. Both homozygous human LDLR (Ldlrh/h) mice and heterozygous human LDLR (Ldlrh/+) mice are viable and fertile with a ~40% reduction in steady state plasma cholesterol. The reduction is primarily in the HDL cholesterol fraction, resulting in elevated non-HDL/HDL cholesterol ratio. The HDL cholesterol of Ldlrh/+ mice is <50 mg/dl, and is close to that normally seen in humans. Of note, because of the equivalency in protein expression and reduced HDL between heterozygotes and homozygotes, the Ldlrh/+ genotype has been more extensively characterized.
The dominant type 1 diabetes mutation Akita (Ins2C96Y) has a C96Y amino acid substitution in the insulin II gene; this results in improper folding of pro-insulin in the endoplasmic reticulum and causes eventual pancreatic islet beta-cell death. As a consequence, heterozygous (Ins2C96Y/+) males develop insulin dependent diabetes around one month of age, including hyperglycemia, hypoinsulinemia, polydipsia and polyuria, without obesity or insulitis. Heterozygous males are more severely affected than females.
Stock No. 012307: Mice homozygous for human APOE*4 and heterozygous for human LDLR (Apoe4/4 Ldlrh/+) are called E4h mice. E4h mice are viable and fertile with low plasma cholesterol (normal non-HDL cholesterol) presumably due to increased Ldlr metabolism in the liver. E4h mice are highly sensitive to diet-induced dyslipidemia. Specifically, when maintained on high fat/cholesterol diet mirroring that consumed by humans, E4h animals develop hypercholesterolemia and atherosclerosis. The donating investigator reports mice homozygous for Apoe4 and homozygous for Ldlrh are viable and fertile with no breeding problems.
Stock No. 012628: Mice homozygous for human APOE*4, heterozygous for human LDLR and heterozygous for Akita (Apoe4/4 Ldlrh/+ Ins2C96Y/+) are called E4hAkita mice. E4hAkita mice are viable and fertile. The phenotype of E4hAkita males is described below. E4hAkita males develop spontaneous diabetes (by two months of age) and atherosclerosis. In addition, males are hyperphagic (but have reduced body weight) and hypoinsulinemic, with a modest but significant reduction of plasma triglycerides. Combining the Ldlrh-induced elevation in non-HDL/HDL cholesterol ratio with the diabetes (Akita)-induced increase in small, cholesterol-enriched, apoB48-containing VLDL results in E4hAkita mice having a non-HDL/HDL cholesterol ratio (~3) that is increased ~6-fold compared to wildtype mice and very close to the human ratio (~3). E4hAkita mice exhibit distinct atherosclerotic foam cell lesions in aortic roots, despite having plasma total cholesterol within the normal physiological range (<120 mg/dl) observed for wildtype mice. Of note, no atherosclerosis is reported for apoE4 homozygotes alone (E4 mice), with hLDLR (E4h mice) or with diabetes (E4Akita mice).
Apoe4 Ldlrh Ins2C96Y mice (or E4hAkita mice) harbor two humanized knock-in mutations, the human APOE*4 replacement allele (Apoetm3(APOE*4)Mae) and the human LDLR replacement allele (Ldlrtm1(LDLR)Mae), along with the dominant type 1 diabetes mutation Akita (Ins2Akita).
The human APOE*4 replacement allele (Apoe4, apoE4 or E4) targeting construct was designed by Dr. Nobuyo Maeda (University of North Carolina, Chapel Hill) to insert a DNA sequence from human apolipoprotein E (APOE) exons 2-4 (encoding the APOE*4 isoform) and a neomycin-resistant cassette, such that it replaced the equivalent portions of the mouse Apoe locus on the proximal end of chromosome 7. The construct was electroporated into BK4 embryonic stem (ES) cells (a subclone of the 129P2/OlaHsd-derived E14TG2a ES cell line). Correctly targeted ES cells were injected into recipient blastocysts, and chimeric animals were bred to C57BL/6 mice to establish the mutant colony. The Apoe4 colony was backcrossed at least six generations to C57BL/6 mice. The resulting B6.Apoe4 mice were then used as described below.
Ins2C96Y (Akita or "maturity onset diabetes of the young 4") is a dominant spontaneous mutation with a G to A transition at nucleotide 1907 (encoding Cys to Tyr at amino acid 96) of the insulin II locus (Ins2) on the distal end of chromosome 7. Akita mice on a C57BL/6 background are available and described as Stock No. 003548. Dr. Maeda obtained B6.Akita mice and bred them as described below.
The human LDLR replacement allele (Ldlrh or hLDLR) targeting construct was created by Dr. Nobuyo Maeda (University of North Carolina, Chapel Hill). First, a human low density lipoprotein receptor (LDLR) minigene was created to have a genomic sequence of human LDLR from exon 2 through part of exon 5, followed by a cDNA sequence of human LDLR from part of exon 5 through exon 18 that is modified to encode a more stable mRNA transcript (by deletion of two of the three 3' AU-rich elements in exon 18). The targeting vector, containing the human LDLR minigene followed by a human growth hormone polyA addition signal sequence and a neomycin-resistant cassette, was designed to replace ~8 kbp of sequence spanning intron 1 through most of exon 4 of the mouse Ldlr locus on chromosome 9. The construct was electroporated into 129S6/SvEvTac derived TC-1 ES cells. Correctly targeted ES cells were injected into recipient blastocysts, and chimeric animals were bred to C57BL/6J mice to establish the mutant colony. The Ldlrh colony was backcrossed at least six generations to C57BL/6 mice. The resulting B6.Ldlrh mice were then used as described below.
To generate the triple mutant line, Dr. Maeda first bred B6.Apoe4 mice with B6.Akita mice to identify a recombination event. These mutations are located ~122 Mbp apart on chromosome 7. The double mutant mice were sent to The Jackson Laboratory Repository in 2010. Upon arrival, they were bred with C57BL/6-congenic Apoe4 Ldlrh animals (Stock No. 012307). The resulting triple mutant mice, Apoe4 Ldlrh Ins2C96Y mice are Stock No. 012628. Mice homozygous for human APOE*4, heterozygous for human LDLR and heterozygous for Akita (Apoe4/4 Ldlrh/+ Ins2C96Y/+) are called E4hAkita mice.
Expressed Gene | APOE, apolipoprotein E, human |
---|---|
Site of Expression | Blood plasma. |
Expressed Gene | LDLR, low density lipoprotein receptor, human |
Site of Expression | Plasma. |
Allele Name | Akita |
---|---|
Allele Type | Spontaneous |
Allele Synonym(s) | Akita; AkitaIns2; Ins2C96Y; Ins2Mody; Mody; Mody4 |
Gene Symbol and Name | Ins2, insulin II |
Gene Synonym(s) | |
Strain of Origin | C57BL/6NSlc |
Chromosome | 7 |
Molecular Note | In the mutant allele a transition from G-to-A at coding nucleotide 287 disrupts an Fnu4HI site in exon 3. This mutation changed the seventh amino acid in the A chain of mature insulin, Cys96 (TGC), to Tyr (TAC) (p.C96Y). The authors predict that the transition would disrupt a disulfide bond between the A and the B chains and would likely induce a major conformational change in insulin 2 molecules. RT-PCR studies suggest that both normal and mutant Ins2 alleles are transcribed similarly in pancreatic islets of heterozygous mice, although immunofluorescence and immunoblot analyses of heterozygous islets detected reduced levels of insulin and proinsulin. |
Allele Name | targeted mutation 3, Nobuyo Maeda |
---|---|
Allele Type | Targeted (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | 4; APOE*4; Apoe4; Apoetm3(APOE)Mae; apoe4; apoE4 TR; apoE4-KI; E4; TgH/ApoE4/N8; TRE4 |
Gene Symbol and Name | Apoe, apolipoprotein E |
Gene Synonym(s) | |
Expressed Gene | APOE, apolipoprotein E, human |
Site of Expression | Blood plasma. |
Strain of Origin | 129P2/OlaHsd |
Chromosome | 7 |
Molecular Note | A DNA fragment containing exons 2-4 of the human APOE gene (the APOE4 isoform) replaced an equivalent portion of the mouse Apoe gene. Western blot analysis on plasma derived from homozygous mice demonstrated that the human protein was expressed from this allele and the endogenous mouse protein was not detectable. |
Allele Name | targeted mutation 1, Nobuyo Maeda |
---|---|
Allele Type | Targeted (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | hLDLR; LDLRh |
Gene Symbol and Name | Ldlr, low density lipoprotein receptor |
Gene Synonym(s) | |
Expressed Gene | LDLR, low density lipoprotein receptor, human |
Site of Expression | Plasma. |
Strain of Origin | 129S6/SvEvTac |
Chromosome | 9 |
Molecular Note | About 8 kb of sequence spanning 3' of intron 1 through exon 4 was replaced with the human LDLR minigene containing exons 2-18 of human sequence. The minigene was shortened by a deletion of two of the three 3' AU-rich elements in exon 18. The mature protein transcribed from the chimeric gene was entirely human protein, due to exon 1 encoding only the signal peptide. |
Apoe4 Ins2C96Y Ldlrh mice harbor three mutations; the human APOE*4 replacement allele (Apoetm3(APOE*4)Mae) on the proximal end of chromosome 7, the dominant type 1 diabetes mutation Akita (Ins2Akita) on the distal end of chromosome 7 and the human LDLR replacement allele (Ldlrtm1(LDLR)Mae) on chromosome 9. The Apoe4 and Ins2C96Y mutations are located ~122 Mbp apart on chromosome 7. The donating investigator reports mice homozygous for Apoe4 and homozygous for Ldlrh are viable and fertile with no breeding problems. Of note, because of the equivalency in hLDLR protein expression and reduced HDL between heterozygotes (Ldlrh/+) and homozygotes (Ldlrh/h), the Ldlrh/+ genotype has been more extensively characterized. For all breeding scenarios, using female breeders that are wildtype at the Ins2 locus avoids any diabetes complications for pregnant/nursing dams.
Therefore, when maintaining our live colony, females homozygous for Apoe4 and wildtype at the Ins2 are bred with males homozygous for Apoe4 and heterozygous for Ins2C96Y with the following Ldlr genotypes: Ldlr+/+ females x Ldlrh/+ males, Ldlrh/+ females x Ldlr+/+ males, Ldlrh/h females x Ldlr+/+ males or Ldlr+/+ females x Ldlrh/h males.
When using the B6.Cg-Apoetm3(APOE*4)Mae Ins2Akita Ldlrtm1(LDLR)Mae/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #012628 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Apoe, Heterozygous or wildtype for Akita, Heterozygous or wildtype for Ldlr |
Frozen Mouse Embryo | B6.Cg-Apoe<tm3(APOE*4)Mae> Ins2<Akita> Ldlr<tm1(LDLR)Mae>/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Apoe<tm3(APOE*4)Mae> Ins2<Akita> Ldlr<tm1(LDLR)Mae>/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Apoe<tm3(APOE*4)Mae> Ins2<Akita> Ldlr<tm1(LDLR)Mae>/J | $3373.50 |
Frozen Mouse Embryo | B6.Cg-Apoe<tm3(APOE*4)Mae> Ins2<Akita> Ldlr<tm1(LDLR)Mae>/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.